Pharmaceuticals
Usa
Development
Manufacturing
Prescription
Specializing
Operations
M&A Advisory
Lazard
Full Credential Description
Endo Pharmaceuticals. United States. Announced Date 10/04/2008. Closed Date 15/04/2008. Deal value: $380m. Private offering of convertible senior subordinated notes. Industry: Endo Pharmaceuticals operates in the pharmaceutical industry, specializing in the development and manufacturing of prescription medications.